Yu Kaihai, director of the Provincial Food and Drug Administration, and his entourage came to our company to investigate

On August 28, 2020, Director Yu Kaihai of the Fujian Provincial Food and Drug Administration led six people, including Zheng Chun, director of provincial drug safety, and Li Zong, director of the Provincial Drug Certification and Evaluation Center, to our company to investigate the research and development of drugs. Chen Min, deputy director of Fuzhou Market Supervision Bureau, Lin Wenfeng, deputy director of Cangshan District, as well as the main and responsible leaders of the District Market Supervision Bureau and the leaders of the District Government Office participated in the investigation.

At the symposium, Chairman Kang Xinshan and Vice President Feng Yan, on behalf of the company, thanked provincial and municipal departments at all levels for their strong support to the company, and reported in detail to the research team on the research and development process, production and operation of the company's innovative drugs and generic drugs.

Director Yu Kaihai said in his speech that the main purpose of this survey is to encourage and cheer up Haixi's new drugs. As the first research and development enterprise in the history of Fujian Provincial Food and Drug Administration to issue a drug production license to MAH, Haixi New Pharmaceutical is a typical representative of Fujian drug research and development institutions. In recent years, it has achieved outstanding research and development results. It is hoped that the next stage of Haixi New Medicine will increase scientific and technological innovation and highlight the focus of research and development; strengthen the construction of the talent team and improve the soft power of enterprises; do a good job in industrial scientific layout and enhance market competitiveness; improve the R&D working environment and create representative business cards.

Chairman Kang Xinshan said that Haixi New Pharmaceutical will continue to work hard to adhere to the values and development concepts of "innovation, integrity, sharing and goodwill", and build a benchmark enterprise for drug research and development and drug marketing license holders in Fujian Province.